Table 4.

Multivariate logistic regression analysis of influencing factors of FMD decline at 1-year follow-up

	B	S.E.	Wald	P	Exp (B)	95% CI
Age ≥ 65 years	−1.369	1.198	1.306	0.253	0.254	0.024–2.661
Male gender	−0.619	0.844	0.539	0.463	0.538	0.103–2.815
Hypertension	3.192	1.168	7.470	0.006	24.335	2.467–240.048
Family history of premature cardiovascular diseases	−2.685	1.202	4.987	0.026	0.068	0.006–0.720
Smoking	0.412	1.179	0.122	0.727	1.510	0.150–15.231
HbA1c ≥ 6.5%	−2.829	1.075	6.934	0.008	0.059	0.007–0.485
Total cholesterol	1.078	1.190	0.821	0.365	2.939	0.285–30.277
Low-density lipoprotein cholesterol	−0.582	1.566	0.138	0.710	0.559	0.026–12.030
Systolic blood pressure	−0.103	0.048	4.668	0.031	0.902	0.821–0.990
Pulse pressure	−0.029	0.040	0.526	0.468	0.971	0.898–1.051
Endothelial progenitor cells	0.001	0.014	0.006	0.941	1.001	0.975–1.028
Constant	15.174	5.853	6.722	0.010	3,889,333.926

FMD flow-mediated dilatation